CGNX Q1 2026 Earnings Robust EPS Surprise Overshadowed by Revenue Disappointment LLY Q1 2026 Earnings Earnings Crush Drives Modest Stock Gains as Revenue Details Remain Limited ALAR Q4 2025 Earnings EPS Surges Past Estimates with 39412 Surprise MYRG Q1 2026 Earnings Stunning EPS Beat Drives Stock Higher Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline Nuwellis Q1 2026 Earnings Significant EPS Miss Despite Stock Gain